Tests for gene rearrangements (BCRABL1, FIP1L1-PDGFRα, PDGFRβ, FGFR1, PCM1-JACK3, and PCM1-JAK2) were negative and ruled out malignant tumors of the blood that could be associated with an increase in eosinophils. Here, PCM1 is linked to cancer.